Veronika Bachanova

Professor, Medicine - Hematology, Oncology, Transplant

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

Dive into the research topics where Veronika Bachanova is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

54 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

17 Active
20 Finished

An observational retrospective cohort study of systemic therapies for relapsed or refractory diffuse large B cell lymphoma (R/R DLBCL), to compare outcomes to those from Tafasitamab + Lenalidomide in the L-MIND study
Bachanova, V.
MorphoSys AG
6/30/20 → 4/28/21
Project: Research project
MT2019-40: A Phase I, Open-Label, Multicenter Study of FT596 as a Monotherapy and in Combination withRituximab or Obinutuzumab in Subjects with Relapsed/Refractory B-cell Lymphoma and ChronicLymphocytic Leukemia
Bachanova, V.
Fate Therapeutics, Inc.
10/18/19 → 10/31/24
Project: Research project
A Phase 2, Open-Label, Single-ArmStudy to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patientswith Relapsed or Refractory Hodgkin Lymphoma
Bachanova, V.
ADC THERAPEUTICS SA
7/16/19 → 7/31/24
Project: Research project
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells
Bachanova, V.
Celgene Corporation
3/1/19 → 2/28/35
Project: Research project
Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Hodgkin's LymphomaHodgkin???s Lymphoma
Bachanova, V.
BRISTOL-MYERS SQUIBB COMPANY
8/16/18 → 8/15/28
Project: Research project

87 Article
13 Review article
4 Letter
3 Comment/debate
More
- 2 Chapter
- 2 Editorial

CD33-Targeted Therapies: Beating the Disease or Beaten to Death?
Maakaron, J. E., Rogosheske, J., Long, M., Bachanova, V. & Mims, A. S., Jan 2021, In: Journal of Clinical Pharmacology. 61, 1, p. 7-17 11 p.
Research output: Contribution to journal › Review article › peer-review
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant
Okoev, G., Weisdorf, D. J., Wagner, J. E., Blazar, B. R., MacMillan, M. L., DeFor, T., Lazaryan, A., El Jurdi, N., Holtan, S. G., Brunstein, C. G., Betts, B., Takahashi, T., Bachanova, V., Warlick, E. D., Rashidi, A. & Arora, M., 2021, (Accepted/In press) In: Bone marrow transplantation.
Research output: Contribution to journal › Article › peer-review
Bispecific targeting of EGFR and urokinase receptor (uPAR) using ligand-targeted toxins in solid tumors
Oh, F., Modiano, J. F., Bachanova, V. & Vallera, D. A., Jun 2020, In: Biomolecules. 10, 6, p. 1-13 13 p., 956.
Research output: Contribution to journal › Review article › peer-review

Open Access
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
Zhang, S., Kulkarni, A. A., Xu, B., Chu, H., Kourelis, T., Go, R. S., Wang, M. L., Bachanova, V. & Wang, Y., Mar 1 2020, In: Blood cancer journal. 10, 3, 33.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
The CAR T-cell Consortium, Jul 2020, In: Biology of Blood and Marrow Transplantation. 26, 7, p. 1239-1246 8 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
18 Scopus citations